Biodegradable patching plaster

Biodegradable patching plaster Focal Inc. advanced its device-based approach to restenosis by receiving a U.S. patent for an internal "paving" technology that claims drug delivery applications as well.

The company's Pavent is a biodegradable compound that, when heated, forms a thin, conforming layer of polymers to the inner surfaces of body organs. Stephen Rowe, director of business development, said the system initially will be developed as a replacement for the metallic stent used in restenosis patients...